PJVQX
Price
$22.59
Change
-$0.06 (-0.26%)
Updated
Jun 5 closing price
Net Assets
620.3M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

PJVQX vs RMEBX

Header iconPJVQX vs RMEBX Comparison
Open Charts PJVQX vs RMEBXBanner chart's image
PGIM Jennison Value R6
Price$22.59
Change-$0.06 (-0.26%)
VolumeN/A
Net Assets620.3M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
PJVQX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PJVQX vs. RMEBX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PJVQX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. PJVQX (620M). PJVQX pays higher dividends than RMEBX: PJVQX (2.02) vs RMEBX (1.16). PJVQX was incepted earlier than RMEBX: PJVQX (14 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than PJVQX (0.51). RMEBX is a more actively managed with annual turnover of: 31.00 vs. PJVQX (29.00). PJVQX has a lower initial minimum investment than RMEBX: PJVQX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. PJVQX (4.34). RMEBX return over 5 years is better than : 49.85 vs. PJVQX (39.87).
PJVQXRMEBXPJVQX / RMEBX
Total Expense Ratio0.441.0741%
Annual Report Gross Expense Ratio0.511.0748%
Fund Existence14 years11 years-
Gain YTD1.3425.34925%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets620M105B1%
Annual Yield % from dividends2.021.16175%
Returns for 1 year4.348.3052%
Returns for 3 years12.0417.9667%
Returns for 5 years39.8749.8580%
Returns for 10 years18.3568.2127%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA